PrimeVigilance looks forward to attending the upcoming World Drug Safety Congress Americas 2024 that will take place in Boston, MA from 29-30 October.

 

The World Drug Safety Congress Americas 2024, taking place from 29–30 October 2024 in Boston, is a premier event for professionals in drug safety and pharmacovigilance. With a strong tradition of delivering cutting-edge content, the congress focuses on innovations and best practices in drug safety, compliance, and regulatory affairs.

If you’re attending, be sure to visit PrimeVigilance’s Booth #736. Our team of experts will be available to discuss how our full suite of drug safety and pharmacovigilance services can help you navigate complex regulatory frameworks and optimize patient safety strategies. From risk management and regulatory compliance to comprehensive pharmacovigilance services, we are committed to supporting you in every aspect of drug safety.

 

PrimeVigilance Expert Session

Don’t miss the opportunity to hear from Jim Leaver, PhD, Vice President of Medical Information at PrimeVigilance, who will be speaking on October 30 at 12:25 on the topic of “Driving quality and compliance through integrated PVMI services“.

 

Meet our Experts at #WDSCAmericas24!

Valerie Leray
Senior Vice President, Global Head of Project Management and Strategic Partnerships

Cecily Johnson
Senior Director / Business Unit Lead, Medical Devices & Innovative Products

Meera Sivasundram
Vice President, Business Development, Pharmacovigilance Strategy

Luis Encarnacion
Vice President, Business Development

Chris Agresti
Director, Business Development

Chad Emmenecker
Director, Business Development

Tom Steen
Director, Business Development

Jimmy King
Sales Development Account Manager

 

 

We look forward to seeing you there!

To maximize your experience, we invite you to schedule a meeting with our experts to discuss how PrimeVigilance can tailor its services to meet your specific pharmacovigilance and regulatory needs. Whether you’re exploring the latest in AI-driven solutions or seeking guidance on global compliance, our team is here to help you succeed in your drug safety initiatives in the fast-evolving pharmaceutical landscape.